Search

Search Constraints

You searched for: Author/Creator Malone, Michele

Search Results

1. 8th GCC: Consolidated feedback to US FDA on the 2013 Draft FDA Guidance on Bioanalytical Method Validation. (November 2014)

2. 9th GCC closed forum: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooks. (March 2016)

3. Conference Report: 4th Global CRO Council for Bioanalysis: coadministered drugs stability, EMA/US FDA Guidelines, 483s and Carryover. (April 2012)

4. Conference Report: 6th GCC focus on LBA: critical reagents, positive controls and reference standards; specificity for endogenous compounds; biomarkers; biosimilars. (October 2012)

5. Formation of a Global Contract Research Organization Council for Bioanalysis. (November 2010)

6. Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC). (September 2012)

7. Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC). (September 2012)

8. Recommendations on biomarker bioanalytical method validation by GCC. (October 2012)

9. Recommendations on biomarker bioanalytical method validation by GCC. (October 2012)

10. Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC). (March 2012)